Drugs / StrataGraft Skin Tissue
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01437852 | Sep 2011 → Jan 2014 | — | Stratatech, a Mallinckrodt Company | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04123548 | Feb 2020 → Jan 2022 | — | Stratatech, a Mallinckrodt Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | StrataGraft Skin Tissue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01437852 ↗ |
| Modality | Other / unclassified | “StrataGraft skin tissue was an investigational tissue” NCT04123548 ↗ |
| Route | Topical | “single topical application” NCT04123548 ↗ |